Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

NCT01090622 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Erythromelalgia
Inherited Erythromelalgia

Interventions

DRUG: XPF-001
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.